A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease

ABSTRACT Naturally acquired opsonic antipneumococcal antibodies are commonly found in nonvaccinated adults and confer protection against infection and colonization. Despite this, only limited data exist regarding the adaptive immune response after pneumococcal exposure. To investigate the dynamics o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fabian Uddén, Jonas Ahl, Nils Littorin, Kristoffer Strålin, Simon Athlin, Kristian Riesbeck
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://doaj.org/article/9539cbd50a3249ca948e9f06e822a6de
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9539cbd50a3249ca948e9f06e822a6de
record_format dspace
spelling oai:doaj.org-article:9539cbd50a3249ca948e9f06e822a6de2021-11-15T15:27:52ZA Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease10.1128/mSphere.00925-192379-5042https://doaj.org/article/9539cbd50a3249ca948e9f06e822a6de2020-02-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00925-19https://doaj.org/toc/2379-5042ABSTRACT Naturally acquired opsonic antipneumococcal antibodies are commonly found in nonvaccinated adults and confer protection against infection and colonization. Despite this, only limited data exist regarding the adaptive immune response after pneumococcal exposure. To investigate the dynamics of naturally acquired antipneumococcal immunity in relation to an episode of infection, opsonic antibody activity was studied with paired acute-phase and convalescent-phase sera obtained from 54 patients with pneumococcal community-acquired pneumonia (CAP) using an opsonophagocytic assay (OPA). Results were compared with clinical characteristics and anticapsular immunoglobulin (Ig) concentrations. Interestingly, a nonfunctional opsonic antibody response (characterized by a decreased convalescent-phase serum OPA titer compared to that of the acute-phase serum or undetectable titers in both sera) was observed in 19 (35%) patients. A nonfunctional convalescent-phase response was significantly more common among patients with invasive pneumococcal disease (i.e., bacteremia) than in patients without invasive disease (53%; P = 0.019). Remaining individuals exhibited either an increased convalescent-phase OPA titer (n = 24 [44%]) or a detectable, but unchanged, titer at both time points (n = 11 [20%]). No correlation was found between anticapsular Ig concentrations and OPA titers. Our findings indicate that an episode of pneumococcal infection may act as an immunizing event, leading to an improved antipneumococcal adaptive immune status. However, in some cases, when patients with CAP also suffer from bacteremia, a nonfunctional opsonic antibody response may occur. Furthermore, the results suggest that factors other than anticapsular Ig concentrations are important for opsonic antibody activity in serum. IMPORTANCE Numerous reports on the dynamics of antipneumococcal immunity in relation to immunization with pneumococcal vaccines and on the prevalence of naturally acquired immunity in various populations have been published. In contrast, studies on the dynamics of the humoral immune response triggered by pneumococcal infection are scarce. This study provides valuable information that will contribute to fill this knowledge gap. Our main results indicate that a functional immune response frequently fails to occur after CAP, predominantly among patients with simultaneous bacteremia.Fabian UddénJonas AhlNils LittorinKristoffer StrålinSimon AthlinKristian RiesbeckAmerican Society for Microbiologyarticleadaptive immune responsebacteremiaimmunoglobulinsopsonizationphagocytosispneumoniaMicrobiologyQR1-502ENmSphere, Vol 5, Iss 1 (2020)
institution DOAJ
collection DOAJ
language EN
topic adaptive immune response
bacteremia
immunoglobulins
opsonization
phagocytosis
pneumonia
Microbiology
QR1-502
spellingShingle adaptive immune response
bacteremia
immunoglobulins
opsonization
phagocytosis
pneumonia
Microbiology
QR1-502
Fabian Uddén
Jonas Ahl
Nils Littorin
Kristoffer Strålin
Simon Athlin
Kristian Riesbeck
A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease
description ABSTRACT Naturally acquired opsonic antipneumococcal antibodies are commonly found in nonvaccinated adults and confer protection against infection and colonization. Despite this, only limited data exist regarding the adaptive immune response after pneumococcal exposure. To investigate the dynamics of naturally acquired antipneumococcal immunity in relation to an episode of infection, opsonic antibody activity was studied with paired acute-phase and convalescent-phase sera obtained from 54 patients with pneumococcal community-acquired pneumonia (CAP) using an opsonophagocytic assay (OPA). Results were compared with clinical characteristics and anticapsular immunoglobulin (Ig) concentrations. Interestingly, a nonfunctional opsonic antibody response (characterized by a decreased convalescent-phase serum OPA titer compared to that of the acute-phase serum or undetectable titers in both sera) was observed in 19 (35%) patients. A nonfunctional convalescent-phase response was significantly more common among patients with invasive pneumococcal disease (i.e., bacteremia) than in patients without invasive disease (53%; P = 0.019). Remaining individuals exhibited either an increased convalescent-phase OPA titer (n = 24 [44%]) or a detectable, but unchanged, titer at both time points (n = 11 [20%]). No correlation was found between anticapsular Ig concentrations and OPA titers. Our findings indicate that an episode of pneumococcal infection may act as an immunizing event, leading to an improved antipneumococcal adaptive immune status. However, in some cases, when patients with CAP also suffer from bacteremia, a nonfunctional opsonic antibody response may occur. Furthermore, the results suggest that factors other than anticapsular Ig concentrations are important for opsonic antibody activity in serum. IMPORTANCE Numerous reports on the dynamics of antipneumococcal immunity in relation to immunization with pneumococcal vaccines and on the prevalence of naturally acquired immunity in various populations have been published. In contrast, studies on the dynamics of the humoral immune response triggered by pneumococcal infection are scarce. This study provides valuable information that will contribute to fill this knowledge gap. Our main results indicate that a functional immune response frequently fails to occur after CAP, predominantly among patients with simultaneous bacteremia.
format article
author Fabian Uddén
Jonas Ahl
Nils Littorin
Kristoffer Strålin
Simon Athlin
Kristian Riesbeck
author_facet Fabian Uddén
Jonas Ahl
Nils Littorin
Kristoffer Strålin
Simon Athlin
Kristian Riesbeck
author_sort Fabian Uddén
title A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease
title_short A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease
title_full A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease
title_fullStr A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease
title_full_unstemmed A Nonfunctional Opsonic Antibody Response Frequently Occurs after Pneumococcal Pneumonia and Is Associated with Invasive Disease
title_sort nonfunctional opsonic antibody response frequently occurs after pneumococcal pneumonia and is associated with invasive disease
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/9539cbd50a3249ca948e9f06e822a6de
work_keys_str_mv AT fabianudden anonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT jonasahl anonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT nilslittorin anonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT kristofferstralin anonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT simonathlin anonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT kristianriesbeck anonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT fabianudden nonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT jonasahl nonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT nilslittorin nonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT kristofferstralin nonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT simonathlin nonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
AT kristianriesbeck nonfunctionalopsonicantibodyresponsefrequentlyoccursafterpneumococcalpneumoniaandisassociatedwithinvasivedisease
_version_ 1718427965515104256